CADTH | Evidence Driven
CADTH | Evidence Driven

Therapeutic Drug Monitoring of Vancomycin: Clinical Evidence and Cost-Effectiveness

Details

Files
Project Line:
Reference List
Project Sub Line:
Reference List
Project Number:
RA1031-000

Question

  1. What is the clinical evidence regarding using area under the curve to a minimum inhibitory concentration ratio versus trough level dosing for the administration of vancomycin?
  2. What is the cost-effectiveness of therapeutic drug monitoring of vancomycin using area under the curve to a minimum inhibitory concentration ratio versus trough level for people with serious infections?

Key Message

Two non-randomized studies were identified regarding the clinical effectiveness of therapeutic drug monitoring of vancomycin. No relevant economic evaluations were identified regarding cost-effectiveness of therapeutic drug monitoring of vancomycin.

Files

Therapeutic Drug Monitoring of Vancomycin: Clinical Evidence and Cost-Effectiveness Rapid Response May 9, 2019 View PDF
Last Updated : May 9, 2019